663 related articles for article (PubMed ID: 26769181)
1. MicroRNA-106b is involved in transforming growth factor β1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma.
Cheng Y; Guo Y; Zhang Y; You K; Li Z; Geng L
J Exp Clin Cancer Res; 2016 Jan; 35():11. PubMed ID: 26769181
[TBL] [Abstract][Full Text] [Related]
2. Substrate stiffness affects epithelial-mesenchymal transition of cervical cancer cells through miR-106b and its target protein DAB2.
Piao J; You K; Guo Y; Zhang Y; Li Z; Geng L
Int J Oncol; 2017 Jun; 50(6):2033-2042. PubMed ID: 28498390
[TBL] [Abstract][Full Text] [Related]
3. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
[TBL] [Abstract][Full Text] [Related]
4. miR-27a inhibits cervical adenocarcinoma progression by downregulating the TGF-βRI signaling pathway.
Fang F; Huang B; Sun S; Xiao M; Guo J; Yi X; Cai J; Wang Z
Cell Death Dis; 2018 Mar; 9(3):395. PubMed ID: 29531222
[TBL] [Abstract][Full Text] [Related]
5. MiR-93 functions as a tumor promoter in prostate cancer by targeting disabled homolog 2 (DAB2) and an antitumor polysaccharide from green tea (Camellia sinensis) on their expression.
Yang K; Li YW; Gao ZY; Xiao W; Li TQ; Song W; Zheng J; Chen H; Chen GH; Zou HY
Int J Biol Macromol; 2019 Mar; 125():557-565. PubMed ID: 30543885
[TBL] [Abstract][Full Text] [Related]
6. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
Tian X; Zhang Z
IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
[TBL] [Abstract][Full Text] [Related]
7. Baicalin exerts anti-tumor effects in oral squamous cell carcinoma by inhibiting the microRNA-106b-5p-Wnt/β-catenin pathway via upregulating disabled homolog 2.
Wang X; Zhang Y; Zhang S; Duan L
Arch Oral Biol; 2021 Oct; 130():105219. PubMed ID: 34364169
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2.
Xu YF; Mao YP; Li YQ; Ren XY; He QM; Tang XR; Sun Y; Liu N; Ma J
Cancer Lett; 2015 Jul; 363(2):146-55. PubMed ID: 25892549
[TBL] [Abstract][Full Text] [Related]
9. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
Cheng KY; Hao M
Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor (TGF) β1 acted through miR-130b to increase integrin α5 to promote migration of colorectal cancer cells.
Yi R; Li Y; Wang F; Gu J; Isaji T; Li J; Qi R; Zhu X; Zhao Y
Tumour Biol; 2016 Aug; 37(8):10763-73. PubMed ID: 26873488
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene.
Li H; Sheng Y; Zhang Y; Gao N; Deng X; Sheng X
Gynecol Oncol; 2017 Jun; 145(3):569-576. PubMed ID: 28385388
[TBL] [Abstract][Full Text] [Related]
12. The effects of Micro-429 on inhibition of cervical cancer cells through targeting ZEB1 and CRKL.
Wang Y; Dong X; Hu B; Wang XJ; Wang Q; Wang WL
Biomed Pharmacother; 2016 May; 80():311-321. PubMed ID: 27133071
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
Luo M; Shen D; Zhou X; Chen X; Wang W
Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
[TBL] [Abstract][Full Text] [Related]
14. LncRNA-CTS promotes metastasis and epithelial-to-mesenchymal transition through regulating miR-505/ZEB2 axis in cervical cancer.
Feng S; Liu W; Bai X; Pan W; Jia Z; Zhang S; Zhu Y; Tan W
Cancer Lett; 2019 Nov; 465():105-117. PubMed ID: 31499118
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression.
Cao Q; Liu F; Ji K; Liu N; He Y; Zhang W; Wang L
J Exp Clin Cancer Res; 2017 Feb; 36(1):29. PubMed ID: 28193228
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
[TBL] [Abstract][Full Text] [Related]
18. MiR-9 is involved in TGF-β1-induced lung cancer cell invasion and adhesion by targeting SOX7.
Han L; Wang W; Ding W; Zhang L
J Cell Mol Med; 2017 Sep; 21(9):2000-2008. PubMed ID: 28266181
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1.
Zhang GJ; Li JS; Zhou H; Xiao HX; Li Y; Zhou T
J Exp Clin Cancer Res; 2015 Jul; 34(1):73. PubMed ID: 26223867
[TBL] [Abstract][Full Text] [Related]
20. LncRNA GAS5 confers the radio sensitivity of cervical cancer cells via regulating miR-106b/IER3 axis.
Gao J; Liu L; Li G; Cai M; Tan C; Han X; Han L
Int J Biol Macromol; 2019 Apr; 126():994-1001. PubMed ID: 30579899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
